85 related articles for article (PubMed ID: 22285820)
1. Application of a risk analysis method to different technologies for producing a monoclonal antibody employed in hepatitis B vaccine manufacturing.
Milá L; Valdés R; Tamayo A; Padilla S; Ferro W
Biologicals; 2012 Mar; 40(2):118-28. PubMed ID: 22285820
[TBL] [Abstract][Full Text] [Related]
2. Expression and characterization of an anti-(hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen.
Ramírez N; Rodríguez M; Ayala M; Cremata J; Pérez M; Martínez A; Linares M; Hevia Y; Páez R; Valdés R; Gavilondo JV; Selman-Housein G
Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):223-30. PubMed ID: 12797866
[TBL] [Abstract][Full Text] [Related]
3. Differential N-glycosylation of a monoclonal antibody expressed in tobacco leaves with and without endoplasmic reticulum retention signal apparently induces similar in vivo stability in mice.
Triguero A; Cabrera G; Rodríguez M; Soto J; Zamora Y; Pérez M; Wormald MR; Cremata JA
Plant Biotechnol J; 2011 Dec; 9(9):1120-30. PubMed ID: 21819534
[TBL] [Abstract][Full Text] [Related]
4. Procurement of reference materials against recombinant HBsAg surface antigen.
Abrahantes Mdel C; Reyes B; Reyes J; Sosa R; González EM; Vega M; Valdés R; Martínez E
J Immunoassay Immunochem; 2002; 23(2):229-44. PubMed ID: 12033645
[TBL] [Abstract][Full Text] [Related]
5. Influence of culture conditions on the N-glycosylation of a monoclonal antibody specific for recombinant hepatitis B surface antigen.
Cabrera G; Cremata JA; Valdés R; García R; González Y; Montesino R; Gómez H; González M
Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):67-76. PubMed ID: 15049731
[TBL] [Abstract][Full Text] [Related]
6. Prolonged stability of the plantibody HB-01 directed against the hepatitis B surface antigen in cryo-preserved tobacco leaves.
Ferro W; Geada D; Guevara Y; Padilla S; Conde A; Alvarez T; Medina Y; González T; Wood M; Valdés R
Biologicals; 2010 May; 38(3):415-9. PubMed ID: 20303783
[TBL] [Abstract][Full Text] [Related]
7. Transgenic tobacco cells producing the human monoclonal antibody to hepatitis B virus surface antigen.
Yano A; Maeda F; Takekoshi M
J Med Virol; 2004 Jun; 73(2):208-15. PubMed ID: 15122794
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of group-specific a antigen in hepatitis B vaccines by anti-HBs/a monoclonal antibody.
Yamamoto H; Satoh T; Kiyohara T; Totsuka A; Moritsugu Y
Biologicals; 1997 Dec; 25(4):373-80. PubMed ID: 9467033
[TBL] [Abstract][Full Text] [Related]
9. [Production and characterization of monoclonal antibodies directed against the hepatitis B surface antigen].
Pujol FH; Rodríguez I; Liprandi F
Acta Cient Venez; 1992; 43(4):235-9. PubMed ID: 1343738
[TBL] [Abstract][Full Text] [Related]
10. An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification.
Pujol M; Ramírez NI; Ayala M; Gavilondo JV; Valdés R; Rodríguez M; Brito J; Padilla S; Gómez L; Reyes B; Peral R; Pérez M; Marcelo JL; Milá L; Sánchez RF; Páez R; Cremata JA; Enríquez G; Mendoza O; Ortega M; Borroto C
Vaccine; 2005 Mar; 23(15):1833-7. PubMed ID: 15734051
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B vaccine.
Capiau C
Dev Biol Stand; 1998; 96():127-9. PubMed ID: 9890526
[No Abstract] [Full Text] [Related]
13. Monoclonal antibodies specific for hepatitis B e antigen and hepatitis B core antigen.
Sogut I; Hatipoglu I; Kanbak G; Basalp A
Hybridoma (Larchmt); 2011 Oct; 30(5):475-9. PubMed ID: 22008076
[TBL] [Abstract][Full Text] [Related]
14. Plant-based vaccines against human hepatitis B virus.
Shchelkunov SN; Shchelkunova GA
Expert Rev Vaccines; 2010 Aug; 9(8):947-55. PubMed ID: 20673016
[TBL] [Abstract][Full Text] [Related]
15. Enhanced immunogenicity in mice with hepatitis B vaccine complexed to human hepatitis B immunoglobulin.
Wen YM; Guo SQ; Zhang W; Yan XH; Li PY
Chin Med J (Engl); 1994 Oct; 107(10):741-4. PubMed ID: 7835099
[TBL] [Abstract][Full Text] [Related]
16. New downstream processing strategy for the purification of monoclonal antibodies from transgenic tobacco plants.
Platis D; Drossard J; Fischer R; Ma JK; Labrou NE
J Chromatogr A; 2008 Nov; 1211(1-2):80-9. PubMed ID: 18945431
[TBL] [Abstract][Full Text] [Related]
17. [Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the Case-Essalud National Hospital, Arequipa September 1995-March 2002].
Campos Nizama J
Rev Gastroenterol Peru; 2005; 25(2):141-9. PubMed ID: 16021199
[TBL] [Abstract][Full Text] [Related]
18. [The purification of recombinated granulysin and the preparation of its monoclonal antibody].
Ju J; Li XL; Wang WX; Xu XH; Ma YR; Li P; Xie Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jun; 26(6):563-5. PubMed ID: 20734534
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody against non-dominant epitopes of HBV e Ag was raised by antigen-antibody co-immunization.
Yan LC; Jing CY; Huang CF; Ji YY; Yao G; Cai XF; Sun B
J Biotechnol; 2007 May; 129(4):620-7. PubMed ID: 17408795
[TBL] [Abstract][Full Text] [Related]
20. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.
Waters JA; Kennedy M; Voet P; Hauser P; Petre J; Carman W; Thomas HC
J Clin Invest; 1992 Dec; 90(6):2543-7. PubMed ID: 1281839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
